Aarey Drugs

Aarey_Drugs29 Apr 2024

Pharmaceuticals

₹

-1.92 (-3.50%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Aarey Drugs

Aarey Drugs

Pharmaceuticals

Aarey_Drugs29 Apr 2024

₹

-1.92 (-3.50%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
30-Nov-2018	D	Aarey Drugs & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 30, 2018, have passed the following resolutions:- the Board of Directors of the Company has declared an interim dividend of 1% per equity share of Rs. 10 each (10 paise per equity share). The Board of Directors of the company has declared an interim dividend of 1% per equity share of Rs. 10 each (10 paise per equity share) and has fixed December 14, 2018 as record date for the purpose of declaring the interim dividend.	13-Dec-2018
15-Jun-2012	B	SUB. :- Bonus issue of Aarey Drugs and Pharmaceuticals Ltd. (Scrip Code: 524412) Trading Members of the Exchange are hereby informed that Aarey Drugs and Pharmaceuticals Ltd. has fixed the Record Date for the purpose of Bonus Issue. The transactions in the equity shares of the Company should be on an ex-bonus basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Aarey Drugs and Pharmaceuticals Ltd. (524412) RECORD DATE 26.06.2012 PURPOSE Issue of 1 (ONE)) fully paid up Bonus equity share of Rs. 10/- each for every 5 (FIVE) fully paid up equity shares of Rs. 10/- each held. Ex-Bonus basis from Date & Sett. No. 25/06/2012 DR-061/2012-2013 Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 18.06.2012)	26-Jun-2012	1:5
10-Jan-2012	R	SUB. :- Rights issue of Equity Shares of Aarey Drugs & Pharmaceuticals Ltd. (Scrip Code 524412) Trading Members of the Exchange are hereby informed that, Aarey Drugs & Pharmaceuticals Ltd. has fixed the Record Date for the purpose of Rights Issue of Equity Shares. The transactions in the equity shares of the Company should be done on ex-rights basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Aarey Drugs & Pharmaceuticals Ltd. (524412) RECORD DATE 20.01.2012 PURPOSE Issue of 2 (TWO) Equity Shares of Rs. 10/- each for cash at premium of Rs. 15/- per share on rights basis for every 1 (ONE) equity share of Rs. 10/- held. Ex-Right basis from Date & Sett. No. 19/01/2012 DR-202/2011-2012 Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 11.01.2012)	20-Jan-2012	2:1
20-Mar-2024	BC	AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/03/2024 inter alia to consider and approve Allotment of Equity Shares a	27-Mar-2024
06-Feb-2024	BC	AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Unaudited Financial result.	14-Feb-2024
06-Dec-2023	BC	EGM 29/12/2023 Newspaper Publication (As Per BSE Announcement dated on 14.12.2023) Outcome Scrutinizers Report (As per BSE Announcement Dated on 29/12/2023)	29-Dec-2023
04-Nov-2023	BC	AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2023 inter alia to consider and approve Unaudited Financial result f	11-Nov-2023
09-Oct-2023	BC	Outcome for appointment and resignation	09-Oct-2023

Record Date01 Jan'1900

Ex-Rights Date01 Jan'1900

Premium(Rs.)15

Ratio2:1

Book Closure

Record Date	Split Date	Purpose
27-Mar-2024	-	AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/03/2024 inter alia to consider and approve Allotment of Equity Shares a
14-Feb-2024	-	AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Unaudited Financial result.
29-Dec-2023	-	EGM 29/12/2023 Newspaper Publication (As Per BSE Announcement dated on 14.12.2023) Outcome Scrutinizers Report (As per BSE Announcement Dated on 29/12/2023)
11-Nov-2023	-	AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2023 inter alia to consider and approve Unaudited Financial result f
09-Oct-2023	-	Outcome for appointment and resignation

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Aarey Drugs & Pharmaceuticals Ltd ₹53.00(-1.92/-3.50%)	53.00	-1.92	139.41	100.15	33.08	1.17
Astrazeneca Pharma India Ltd ₹5,550.00(+134.60/2.49%)	5,550.00	+134.60	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹124.45(+1.85/1.51%)	124.45	+1.85	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,407.55(-1.85/-0.13%)	1,407.55	-1.85	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹26,264.85(+400.00/1.55%)	26,264.85	+400.00	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹710.40(+29.55/4.34%)	710.40	+29.55	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	76.48	57.83	50.96	162.88	62.47	76.26
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	76.48	57.83	50.96	162.88	62.47	76.26
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.29	0.84	0.70	0.84	0.48	-0.94
Total Income	76.77	58.67	51.65	163.72	62.95	75.32
Total Expenditure	73.77	55.98	49.62	160.36	60.94	71.99
PBIDT	3.00	2.68	2.04	3.36	2.01	3.33
Interest	0.47	0.41	0.42	0.20	0.71	0.59
PBDT	2.52	2.27	1.62	3.16	1.30	2.74
Depreciation	1.06	1.27	0.89	1.02	0.55	0.42
Tax	-0.44	-0.22	0.00	1.82	-0.25	0.21
Deferred Tax	0.00	0.00	0.00	-0.04	0.00	0.00
Reported Profit After Tax	1.91	1.23	0.72	0.36	1.00	2.12
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	1.91	1.23	0.72	0.36	1.00	2.12

EPS (Unit Curr.)	0.75	0.48	0.29	0.14	0.39	0.83
EPS (Adj) (Unit Curr.)	0.75	0.48	0.29	0.14	0.39	0.83
Calculated EPS (Unit Curr.)	0.75	0.48	0.29	0.14	0.43	0.83
Calculated EPS (Adj) (Unit Curr.)	0.75	0.48	0.29	0.14	0.43	0.83
Calculated EPS (Ann.) (Unit Curr.)	3.01	1.94	1.14	0.57	1.71	3.34
Calculated EPS (Adj) (Ann.) (Unit Curr.)	3.01	1.94	1.14	0.57	1.71	3.34
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	25.38	25.38	25.38	25.38	23.38	25.38
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	25384684.00	25384684.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	100.00	100.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	3.92	4.63	4.00	2.06	3.22	4.37
PBDTM(%)	3.29	3.93	3.18	1.94	2.08	3.59
PATM(%)	2.50	2.13	1.41	0.22	1.60	2.78

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	25.38	25.38	23.38	23.38	23.38	23.38
Reserves Total	89.71	85.94	73.16	66.65	60.85	54.55
Equity Share Warrants	2.32	2.32	2.32	2.32	2.32	2.32
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	117.41	113.64	98.86	92.35	86.55	80.25
Secured Loans	4.36	3.34	0.00	17.22	16.16	3.11
Unsecured Loans	33.36	10.82	18.02	0.67	0.00	0.13
Total Debt	37.72	14.16	18.02	17.89	16.16	3.24
Total Liabilities	155.13	127.80	116.88	110.24	102.71	83.49
APPLICATION OF FUNDS :
Gross Block	33.17	32.13	29.93	26.40	26.13	24.56
Less : Accumulated Depreciation	19.23	17.66	15.67	14.10	13.86	12.85
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	13.94	14.47	14.26	12.30	12.27	11.71
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.34
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.40	0.40	0.40	0.44	0.44	0.44
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	28.82	13.68	18.46	17.00	21.25	14.77
Sundry Debtors	189.78	136.28	162.01	96.13	105.74	95.30
Cash and Bank	0.71	0.19	0.65	0.50	0.37	3.39
Loans and Advances	51.30	68.66	37.25	67.71	5.63	43.83
Total Current Assets	270.61	218.81	218.38	181.34	132.99	157.29
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	129.50	110.69	111.13	79.75	37.66	81.83
Provisions	5.28	5.23	1.66	2.66	3.86	3.18
Total Current Liabilities	134.78	115.92	112.79	82.41	41.52	85.01
Net Current Assets	135.83	102.90	105.59	98.93	91.47	72.28
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.04	0.11	0.00	0.00	0.00	0.00
Deferred Tax Liability	1.46	1.56	1.56	1.44	1.49	1.30
Net Deferred Tax	-1.42	-1.45	-1.56	-1.44	-1.49	-1.30
Total Assets	148.75	116.32	118.69	110.23	102.69	83.47
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.19	0.65	0.50	0.37	3.39
Net Cash from Operating Activities	-1.28	0.50	5.48	2.86	0.69
Net Cash Used In Investing Activities	0.44	-3.21	-2.88	-0.92	-1.23
Net Cash Used In Financing Activities	1.35	2.25	-2.45	-1.80	-2.48
Net Inc./Dec In Cash And Cash Equivalents	0.51	-0.46	0.15	0.13	-3.02
Cash And Cash Equivalents At End Of The Year	0.71	0.19	0.65	0.50	0.37

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

45.28%

FII Shareholding

3.40%

DII Shareholding

0.00%

Public Shareholding

51.32%

**Promoter pledged shareholding 45.28%

About Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 139.41 crores. It has reported a sales of Rs. 76.48 crores and a net profit of Rs. 1.91 crores for the quarter ended December 2018. The company management includes Mihir R Ghatalia, Mihir R Ghatalia,Chetan K Mehta,Preeti Paresh Rathi,Lalit Tulsiani,Nimit R Ghatalia,Anil Mandal,Bina Ghatalia (Aarey Drugs & Pharmaceuticals Ltd) among others.

Chairman

Mihir R Ghatalia

Registered office

E-34 MIDC Tarapur,Boisar,Thane,Maharashtra,401506

FAX :

Background

Incorporation Year1990

Face Value₹10

Market Lot1

How to buy Aarey Drugs shares on nse?

To buy Aarey Drugs shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Aarey Drugs share price today?

The Aarey Drugs shares price on nse is Rs.53 today.

What is the market cap of Aarey Drugs shares on BSE ?

The company has a market capitalization of Rs.139.41Cr

What is the PE & PB ratio of Aarey Drugs shares ?

PE is 33.08 and PB is 1.17

What is the 52 Week High and Low of Aarey Drugs shares?

Aarey Drugs stock price high: Rs.68 Aarey Drugs stock price low: Rs.26.82